BRPI0615678A2 - método para diagnosticar infecções - Google Patents
método para diagnosticar infecções Download PDFInfo
- Publication number
- BRPI0615678A2 BRPI0615678A2 BRPI0615678-9A BRPI0615678A BRPI0615678A2 BR PI0615678 A2 BRPI0615678 A2 BR PI0615678A2 BR PI0615678 A BRPI0615678 A BR PI0615678A BR PI0615678 A2 BRPI0615678 A2 BR PI0615678A2
- Authority
- BR
- Brazil
- Prior art keywords
- organism
- antigens
- surface antigens
- map
- test sample
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 109
- 208000015181 infectious disease Diseases 0.000 title abstract description 47
- 239000000427 antigen Substances 0.000 claims abstract description 168
- 102000036639 antigens Human genes 0.000 claims abstract description 166
- 108091007433 antigens Proteins 0.000 claims abstract description 166
- 241001465754 Metazoa Species 0.000 claims abstract description 36
- 244000005700 microbiome Species 0.000 claims abstract description 33
- 238000012360 testing method Methods 0.000 claims description 115
- 210000002966 serum Anatomy 0.000 claims description 42
- 239000012530 fluid Substances 0.000 claims description 31
- 239000007787 solid Substances 0.000 claims description 22
- 238000011282 treatment Methods 0.000 claims description 21
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- 238000000527 sonication Methods 0.000 claims description 16
- 241000894006 Bacteria Species 0.000 claims description 10
- 241000186367 Mycobacterium avium Species 0.000 claims description 8
- 108010032595 Antibody Binding Sites Proteins 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 6
- 241000186359 Mycobacterium Species 0.000 claims description 5
- 208000026681 Paratuberculosis Diseases 0.000 claims description 5
- 238000000684 flow cytometry Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 238000004458 analytical method Methods 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 2
- 239000003550 marker Substances 0.000 claims description 2
- 210000002381 plasma Anatomy 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 238000001739 density measurement Methods 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 238000006073 displacement reaction Methods 0.000 abstract description 11
- 241000283690 Bos taurus Species 0.000 description 58
- 239000000523 sample Substances 0.000 description 39
- 201000010099 disease Diseases 0.000 description 34
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 34
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 32
- 238000003745 diagnosis Methods 0.000 description 29
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- 238000002405 diagnostic procedure Methods 0.000 description 18
- 230000035945 sensitivity Effects 0.000 description 17
- 230000002550 fecal effect Effects 0.000 description 16
- 238000002965 ELISA Methods 0.000 description 15
- 239000000284 extract Substances 0.000 description 12
- 241000180044 Mycobacterium avium subsp. avium Species 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Substances ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 9
- 239000002953 phosphate buffered saline Substances 0.000 description 9
- 238000000605 extraction Methods 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 8
- 239000000725 suspension Substances 0.000 description 8
- 230000002458 infectious effect Effects 0.000 description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N methyl pentane Natural products CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 239000000872 buffer Substances 0.000 description 6
- 239000000834 fixative Substances 0.000 description 6
- 229920001213 Polysorbate 20 Polymers 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N dichloromethane Natural products ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- WEVYAHXRMPXWCK-UHFFFAOYSA-N methyl cyanide Natural products CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 5
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 241000283153 Cetacea Species 0.000 description 4
- 208000011231 Crohn disease Diseases 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 244000000013 helminth Species 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- 238000003260 vortexing Methods 0.000 description 4
- 208000010711 Cattle disease Diseases 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 3
- 239000013024 dilution buffer Substances 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 229940079938 nitrocellulose Drugs 0.000 description 3
- 229920000136 polysorbate Polymers 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000606161 Chlamydia Species 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 102000008070 Interferon-gamma Human genes 0.000 description 2
- 108010074328 Interferon-gamma Proteins 0.000 description 2
- 241000186781 Listeria Species 0.000 description 2
- 241000282849 Ruminantia Species 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000013043 chemical agent Substances 0.000 description 2
- 239000000701 coagulant Substances 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 229960003130 interferon gamma Drugs 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- -1 tertiary butyrol Chemical compound 0.000 description 2
- 241000186046 Actinomyces Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000002198 Annona diversifolia Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000589968 Borrelia Species 0.000 description 1
- 241000282832 Camelidae Species 0.000 description 1
- 241000589876 Campylobacter Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241001466804 Carnivora Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241001126268 Cooperia Species 0.000 description 1
- 241001481833 Coryphaena hippurus Species 0.000 description 1
- 241001125840 Coryphaenidae Species 0.000 description 1
- 241000223935 Cryptosporidium Species 0.000 description 1
- 241000179197 Cyclospora Species 0.000 description 1
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 241000223924 Eimeria Species 0.000 description 1
- 241000498256 Enterobius Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 108010034145 Helminth Proteins Proteins 0.000 description 1
- 241000282838 Lama Species 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 241000283960 Leporidae Species 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000428199 Mustelinae Species 0.000 description 1
- 206010062207 Mycobacterial infection Diseases 0.000 description 1
- 241001137882 Nematodirus Species 0.000 description 1
- 241001147660 Neospora Species 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 241000510960 Oesophagostomum Species 0.000 description 1
- 241000243795 Ostertagia Species 0.000 description 1
- 241000283203 Otariidae Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000283080 Proboscidea <mammal> Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000223996 Toxoplasma Species 0.000 description 1
- 241000243797 Trichostrongylus Species 0.000 description 1
- 241000223104 Trypanosoma Species 0.000 description 1
- 241000282458 Ursus sp. Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 241000607734 Yersinia <bacteria> Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000012148 binding buffer Substances 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 244000079386 endoparasite Species 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 230000000951 immunodiffusion Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical group O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000027531 mycobacterial infectious disease Diseases 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000005789 organism growth Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 210000003281 pleural cavity Anatomy 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 210000004915 pus Anatomy 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/220.156 | 2005-09-06 | ||
| US11/220,156 US7713715B2 (en) | 2005-09-06 | 2005-09-06 | Method for diagnosing infections |
| PCT/US2006/034287 WO2007030391A2 (en) | 2005-09-06 | 2006-09-05 | Method for diagnosing infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0615678A2 true BRPI0615678A2 (pt) | 2011-05-24 |
Family
ID=37830465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0615678-9A BRPI0615678A2 (pt) | 2005-09-06 | 2006-09-05 | método para diagnosticar infecções |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7713715B2 (enExample) |
| EP (1) | EP1928614A4 (enExample) |
| JP (1) | JP2009507243A (enExample) |
| AU (1) | AU2006287702A1 (enExample) |
| BR (1) | BRPI0615678A2 (enExample) |
| CA (1) | CA2621485C (enExample) |
| WO (1) | WO2007030391A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070062460A1 (en) * | 2005-09-21 | 2007-03-22 | Robert Simer | Swine saliva sampling method |
| JP5697991B2 (ja) * | 2008-02-01 | 2015-04-08 | サノフィ パストゥール リミテッドＳａｎｏｆｉ Ｐａｓｔｅｕｒ Ｌｉｍｉｔｅｄ | 診断的アッセイ |
| DE102008029834A1 (de) * | 2008-06-25 | 2010-01-14 | Justus-Liebig-Universität Giessen | Verfahren zum spezifischen Nachweis von MAP-Antikörpern |
| WO2010010914A1 (ja) * | 2008-07-23 | 2010-01-28 | オリンパス株式会社 | 糞便試料からの核酸回収方法、核酸解析方法及び糞便試料処理装置 |
| US9696304B2 (en) | 2012-01-27 | 2017-07-04 | University Of Tennessee Research Foundation | Methods for detecting a biomarker by alternating current electrokinetics |
| JP6185935B2 (ja) | 2012-01-27 | 2017-08-23 | ユニバーシティ オブ テネシー リサーチ ファウンデーション | 交流動電によるバイオマーカーの検出のための方法および装置 |
| CA2988297A1 (en) | 2016-12-28 | 2018-06-28 | University Of Tennessee Research Foundation | Methods for detecting a biomarker by alternating current electrokinetics |
| US20180265887A1 (en) | 2017-03-16 | 2018-09-20 | Jacobs Farm Del Cabo | Basil Plants With High Tolerance to Downy Mildew |
| US11252928B2 (en) | 2017-09-21 | 2022-02-22 | The Condard-Pyle Company | Miniature rose plant named ‘Meibenbino’ |
| US11917978B2 (en) | 2017-09-21 | 2024-03-05 | The Conard Pyle Company | Miniature rose plant named ‘meibenbino’ |
| WO2019143891A1 (en) * | 2018-01-18 | 2019-07-25 | The Penn State Research Foundation | Mycobacterium avium subspecies paratuberculosis immunodiagnostic antigens, methods, and kits comprising same |
| US11944063B2 (en) | 2020-09-30 | 2024-04-02 | Spring Meadow Nursery, Inc. | Hydrangea ‘SMNHPH’ |
| US11155884B1 (en) | 2020-10-16 | 2021-10-26 | Klemm & Sohn Gmbh & Co. Kg | Double-flowering dwarf Calibrachoa |
| EP4321015A3 (en) | 2020-10-16 | 2024-04-17 | Klemm & Sohn GmbH & Co. KG | Double-flowering dwarf calibrachoa |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4139840B4 (de) * | 1990-12-04 | 2005-06-02 | Quidel Corp., San Diego | Antigen-Zubereitung zum Nachweis von H. pylori |
| US6592877B1 (en) * | 1995-09-01 | 2003-07-15 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| US6284255B1 (en) * | 1996-08-29 | 2001-09-04 | Genesis Research & Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| US20020064801A1 (en) * | 1999-12-01 | 2002-05-30 | Ryan Jeffrey R. | Novel and practical serological assay for the clinical diagnosis of leishmaniasis |
| EP1274720A4 (en) * | 2000-04-12 | 2004-08-18 | Human Genome Sciences Inc | FUSION PROTEINS CONTAINING ALBUMIN |
| JP3864230B2 (ja) * | 2003-09-26 | 2006-12-27 | 独立行政法人農業・食品産業技術総合研究機構 | ヨーネ菌抗原タンパク質、該タンパク質をコードする遺伝子、及び該タンパク質を用いるヨーネ病の診断方法 |
-
2005
- 2005-09-06 US US11/220,156 patent/US7713715B2/en not_active Expired - Fee Related
-
2006
- 2006-09-05 BR BRPI0615678-9A patent/BRPI0615678A2/pt not_active IP Right Cessation
- 2006-09-05 WO PCT/US2006/034287 patent/WO2007030391A2/en not_active Ceased
- 2006-09-05 JP JP2008530117A patent/JP2009507243A/ja active Pending
- 2006-09-05 CA CA2621485A patent/CA2621485C/en not_active Expired - Fee Related
- 2006-09-05 EP EP06814088A patent/EP1928614A4/en not_active Withdrawn
- 2006-09-05 AU AU2006287702A patent/AU2006287702A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1928614A2 (en) | 2008-06-11 |
| US20070054334A1 (en) | 2007-03-08 |
| US7713715B2 (en) | 2010-05-11 |
| CA2621485A1 (en) | 2007-03-15 |
| EP1928614A4 (en) | 2009-06-17 |
| WO2007030391A3 (en) | 2007-09-20 |
| CA2621485C (en) | 2013-01-15 |
| AU2006287702A1 (en) | 2007-03-15 |
| WO2007030391A2 (en) | 2007-03-15 |
| JP2009507243A (ja) | 2009-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Poester et al. | Diagnosis of brucellosis | |
| Kim et al. | Evaluation of immunochromatographic assay for serodiagnosis of Brucella canis | |
| Rodolakis et al. | Comparison of Coxiella burnetii shedding in milk of dairy bovine, caprine, and ovine herds | |
| Pereira-Bueno et al. | Evaluation of ovine abortion associated with Toxoplasma gondii in Spain by different diagnostic techniques | |
| DK174032B1 (da) | Sæt samt fremgangsmåde til immunometrisk dosering, der kan anvendes på hele celler | |
| US7713715B2 (en) | Method for diagnosing infections | |
| US7422869B2 (en) | Method for diagnosing infectious diseases | |
| Wanke et al. | Preliminary study of an immunochromatography test for serological diagnosis of canine brucellosis | |
| EP1151135A1 (en) | Rapid immunoassay for cariogenic bacteria | |
| Cvetnic | Brucellosis in wild boar (Sus scrofa) in the Republic of Croati | |
| Loureiro et al. | Laboratorial diagnosis of animal leptospirosis | |
| JP2010502729A (ja) | ヨーネ菌に対する抗体用アッセイ | |
| Prajapati et al. | A review on bovine leptospirosis with special reference to seroprevalence in India | |
| Simten et al. | Diagnosis of Q fever and Brucellosis in aborted ovine fetuses by microbiological, pathological and immunohistochemical methods | |
| Sabry et al. | A polymerase chain reaction and enzyme linked immunosorbent assay based approach for diagnosis and differentiation between vaccinated and infected cattle with Mycobacterium bovis | |
| ÖNGÖR | Determination of Coxiella burnetii in bovine foetuses using PCR and immunohistochemistry | |
| KR101894489B1 (ko) | Igm 반정량적 렙토스피라증 진단 키트 | |
| Al-Farwachi et al. | First Serodiagnosis of Brucella ovis among rams with orchid-epididymitis in Mosul city, Iraq. | |
| de Araújo Teixeira et al. | Risk factors and detection of brucella ovis in naturally infected rams and ewes | |
| Bolin | Leptospirosis in cattle: disease review and update. | |
| Maansi et al. | A review on the diagnosis of brucellosis | |
| Rao et al. | A Review on History and Detection of Salmonella Enterica Typhi | |
| Roseliza et al. | Diagnosis of paratuberculosis by microbiological culture in Veterinary Research Institute from 2001 to 2018. | |
| Graves et al. | Laboratory diagnosis of rickettsial infection | |
| RU2648845C2 (ru) | Способ экспресс-диагностики оспы овец и коз |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012. |